SABS (SAB Biotherapeutics) Institutional Ownership: 93.92% (As of Jul. 13, 2026)


SABS SAB Biotherapeutics Inc SABS
34 GF Score
Price $3.81
! 2 Warning Signs
View Full Analysis

What is SAB Biotherapeutics Institutional Ownership?

SAB Biotherapeutics SABS -3.78% 34 Institutional Ownership is 93.92% as of Jul. 13, 2026. GuruFocus rates SABS with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, SAB Biotherapeutics's institutional ownership is 93.92%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, SAB Biotherapeutics's Insider Ownership is 15.64%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, SAB Biotherapeutics's Float Percentage Of Total Shares Outstanding is 96.29%.

SAB Biotherapeutics Institutional Ownership Historical Data

* Premium members only.

The historical data trend for SAB Biotherapeutics's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SAB Biotherapeutics Institutional Ownership Chart

SAB Biotherapeutics Historical Data

The historical data trend for SAB Biotherapeutics can be seen below:

2025-09-30 2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30
Institutional Ownership 0.97 1.30 1.37 4.61 4.63 4.70 4.14 4.17 4.06 6.79
SABS
34GF Score
SAB Biotherapeutics Inc SABS
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SAB Biotherapeutics Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 93.92% mean?
SAB Biotherapeutics (SABS) has a Institutional Ownership of 93.92% as of Jul. 13, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on SAB Biotherapeutics and its competitors.
Is SAB Biotherapeutics' Institutional Ownership too high?
SAB Biotherapeutics' current Institutional Ownership is 93.92%. Overall, SAB Biotherapeutics has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does SAB Biotherapeutics' Institutional Ownership compare to SRZN and GLSI?
SAB Biotherapeutics' Institutional Ownership of 93.92% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on SAB Biotherapeutics and its competitors. SAB Biotherapeutics's current Institutional Ownership is 93.92%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SAB Biotherapeutics stock overvalued right now?
SAB Biotherapeutics (SABS) has a current Institutional Ownership of 93.92%. The current Institutional Ownership is 93.92%. SAB Biotherapeutics' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For SAB Biotherapeutics (SABS), the current Institutional Ownership is 93.92% as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

SAB Biotherapeutics Business Description

Address 777 West 41st Street, Suite 401, Miami Beach, FL, USA, 33140
SAB Biotherapeutics Inc is a clinical-stage biopharmaceutical company focused on developing multi-specific, high-potency, human immunoglobulin G (hIgG) to treat and prevent immune and autoimmune disorders. The company's lead product candidate, SAB-142, targets autoimmune Type 1 Diabetes (T1D) with a disease-modifying therapeutic approach that aims to change the T1D treatment paradigm by delaying onset and potentially preventing disease progression of Stage 3 T1D patients. It is focused on developing product candidates for disease targets where a differentiated approach has the greatest potential to be either first-in-class against novel targets against complex targets to treat diseases, including type 1 diabetes (T1D) and other autoimmune disorders.
34GF Score

Get the complete analysis for SABS

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.81
Price